Earle A. Chiles Research Institute Revenue and Competitors
Estimated Revenue & Valuation
- Earle A. Chiles Research Institute's estimated annual revenue is currently $5M per year.
- Earle A. Chiles Research Institute's estimated revenue per employee is $91,800
Employee Data
- Earle A. Chiles Research Institute has 54 Employees.
- Earle A. Chiles Research Institute grew their employee count by 23% last year.
Earle A. Chiles Research Institute's People
Name | Title | Email/Phone |
---|
Earle A. Chiles Research Institute Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.6M | 22 | -24% | N/A | N/A |
#2 | $7.9M | 71 | 20% | N/A | N/A |
#3 | $13.9M | 136 | 1% | N/A | N/A |
#4 | $18.3M | 163 | 7% | N/A | N/A |
#5 | $5.9M | 64 | 0% | N/A | N/A |
#6 | $6.1M | 66 | 5% | N/A | N/A |
#7 | $5.1M | 56 | 14% | N/A | N/A |
#8 | $2.4M | 30 | 3% | N/A | N/A |
#9 | $2.7M | 33 | -8% | N/A | N/A |
#10 | $105.5M | 739 | 13% | N/A | N/A |
What Is Earle A. Chiles Research Institute?
The Robert W. Franz Cancer Research Center in the Earle A. Chiles Research Institute is a world-class research facility located within Providence Cancer Center in Portland, Ore. Founded in 1993 by Walter Urba, M.D., Ph.D., director of cancer research, and a team of internationally-recognized scientists, our main area of investigation is cancer immunotherapy, a specialized field of study focused on harnessing the innate power of the immune system to cure cancer. The Earle A. Chiles Research Institute garners more than $4 million annually in federal and other sponsored grant funding and has a research staff of more than 100 team members.
keywords:N/AN/A
Total Funding
54
Number of Employees
$5M
Revenue (est)
23%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $6.8M | 54 | -7% | $0.751M |
#2 | $7M | 54 | 6% | N/A |
#3 | $3.5M | 54 | -4% | N/A |
#4 | $5.8M | 54 | 20% | N/A |
#5 | $6.8M | 54 | 23% | $114.9M |